Skip to main content
. 2023 Jul 13;13:1166877. doi: 10.3389/fonc.2023.1166877

Figure 6.

Figure 6

Decision curve analysis of the nomogram and AJCC tumor staging. (A) 3-year survival benefit in the training cohort. (B) 3-year survival benefit in the validation cohort. (C) 6-year survival benefit in the training cohort. (D) 6-year survival benefit in the validation cohort. (E) 9-year survival benefit in the training cohort. (F) 9-year survival benefit in the validation cohort.